{"id":"W2461953677","doi":"10.2196/resprot.5791","title":"Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study","year":2016,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Calprotectin; Vedolizumab; Discontinuation; Internal medicine; Infliximab; Clinical trial; Adalimumab; Tumor necrosis factor alpha; Gastroenterology; Inflammatory bowel disease; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006826146,0.001100746,0.00119149,0.0006896747,0.0006546308,0.001068607,0.0006331785,0.001375601,0.0009940577],"category_scores_gemma":[0.006778446,0.0007005912,0.001332377,0.0007035238,0.0005940081,0.001002894,0.0006041253,0.001244621,0.0004029736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003340913,"about_ca_system_score_gemma":0.0005930054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003402258,"about_ca_topic_score_gemma":0.0002863363,"domain_scores_codex":[0.9973647,0.001541947,0.0002073582,0.0004264158,0.0002709526,0.0001885934],"domain_scores_gemma":[0.9920896,0.001715533,0.00323579,0.0007885988,0.0006002267,0.001570281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0700011,0.004957311,0.9106772,0.0001363597,0.0008731222,0.0001539787,0.0002291602,0.0002930182,0.002104667,0.00003188161,0.0002047771,0.01033752],"study_design_scores_gemma":[0.008354501,0.07380974,0.9131668,0.0000567248,0.0008682875,0.000555845,0.0001701552,0.001431306,0.0007454709,0.00006003286,0.0007295415,0.00005153309],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9986809,0.0006043267,0.0002374796,0.00004710205,0.00001376577,0.0001486295,0.0001057741,0.000008843413,0.0001531423],"genre_scores_gemma":[0.9985471,0.000161998,0.0006027903,0.00008759995,0.0000704772,0.0001544363,0.0002591929,0.000003914841,0.0001125378],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.006826146,"threshold_uncertainty_score":0.03610057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05923878612701019,"score_gpt":0.4257617430833838,"score_spread":0.3665229569563737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}